Table 4.
Group A (n = 34) | Group B (n = 45) | p-value | |
---|---|---|---|
Clarithromycin | 4 (11.8) | 8 (17.8) | 0.46 |
Metronidazole | 11 (32.4) | 15 (33.3) | 0.93 |
Levofloxacin | 5 (14.7) | 17 (37.8) | 0.02 |
Amoxicillin | 0 | 0 | – |
Tetracycline | 0 | 0 | – |
Group A (n = 34) | Group B (n = 45) | p-value | |
---|---|---|---|
Clarithromycin | 4 (11.8) | 8 (17.8) | 0.46 |
Metronidazole | 11 (32.4) | 15 (33.3) | 0.93 |
Levofloxacin | 5 (14.7) | 17 (37.8) | 0.02 |
Amoxicillin | 0 | 0 | – |
Tetracycline | 0 | 0 | – |